Expression of axotomy-inducible and apoptosis-related genes in sensory nerves of rats with experimental diabetes

被引:24
作者
Burnand, RC
Price, SA
McElhaney, M
Barker, D
Tomlinson, DR
机构
[1] Univ Manchester, Sch Biol Sci, Div Neurosci, Manchester M13 9PT, Lancs, England
[2] Curis Inc, Cambridge, MA USA
来源
MOLECULAR BRAIN RESEARCH | 2004年 / 132卷 / 02期
关键词
axotomy; apoptosis; neuropathy; gene expression; sensory neurones;
D O I
10.1016/j.molbrainres.2004.05.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In diabetes, peripheral nerves suffer deficient neurotrophic support-a situation which resembles axotomy. This raises the question: does inappropriate establishment of an axotomised neuronal phenotype contribute to diabetic neuropathy, and in extremis, does this provoke apoptosis? We hybridized reverse-transcribed RNA, from the dorsal root ganglia (DRG) of 8-week streptozotocin (STZ)-induced diabetic rats, to Affymetrix Rat Genome U34A chips and scanned the array for expression of (a) genes that are upregulated by axotomy, (b) proapoptotic and (c) anti-apoptotic genes. Expression of the axotomy-responsive genes coding for growth-associated protein 43 (GAP-43), galanin, neuropeptide Y (NPY), pre-pro-vasoactive intestinal polypeptide (pre-pro-VIP), neuronal nitric oxide synthase (nNOS), protease nexin 1, heat-shock protein 27 (HSP 27) and myosin light chain kinase II (MLCK II) was unaffected in ganglia from diabetic rats compared to controls; thus, no axotomised phenotype was established. The expression of the majority of proapoptotic genes in the DRG was also unaltered (bax, bad, bid, bok, c-Jun, p38, TNFR1, caspase 3 and NOS2). Similarly there was no change in expression of the majority of antiapoptotic genes (bcl2, bcl-xL, bcl-w, NfkappaB). These alterations in gene expression make it clear that neither axotomy nor apoptotic phenotypes are established in neurones in this model of diabetes. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:235 / 240
页数:6
相关论文
共 49 条
[1]   The role of endogenous nerve growth factor in human diabetic neuropathy [J].
Anand, P ;
Terenghi, G ;
Warner, G ;
Kopelman, P ;
WilliamsChestnut, RE ;
Sinicropi, DV .
NATURE MEDICINE, 1996, 2 (06) :703-707
[2]  
Apfel SC, 2002, INT REV NEUROBIOL, V50, P393
[3]   Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor [J].
Bennett, GS ;
Garrett, NE ;
Diemel, LT ;
Brain, SD ;
Tomlinson, DR .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (07) :1573-1579
[4]   REGULATION OF PROTEASE NEXIN-1 AND ANGIOTENSIN-II RECEPTOR SUBTYPE-1 EXPRESSION - INVERSE RELATIONSHIP IN EXPERIMENTAL-MODELS OF NERVE INJURY [J].
BLEUEL, A ;
MONARD, D .
JOURNAL OF NEUROSCIENCE RESEARCH, 1995, 42 (04) :562-570
[5]   A SIMPLE COLORIMETRIC METHOD FOR DETERMINATION OF PROTEIN [J].
BRAMHALL, S ;
NOACK, N ;
WU, M ;
LOEWENBERG, JR .
ANALYTICAL BIOCHEMISTRY, 1969, 31 (1-3) :146-+
[6]   Sensory neurons with activated caspase-3 survive long-term experimental diabetes [J].
Cheng, C ;
Zochodne, DW .
DIABETES, 2003, 52 (09) :2363-2371
[7]  
Costigan M, 1998, J NEUROSCI, V18, P5891
[8]   Effect of nerve growth factor treatment on p75NTR gene expression in lumbar dorsal root ganglia of streptozocin-induced diabetic rats [J].
Delcroix, JD ;
Michael, GJ ;
Priestley, JV ;
Tomlinson, DR ;
Fernyhough, P .
DIABETES, 1998, 47 (11) :1779-1785
[9]   INCREASED CONTENT AND TRANSPORT OF SUBSTANCE-P AND CALCITONIN GENE-RELATED PEPTIDE IN SENSORY NERVES INNERVATING INFLAMED TISSUE - EVIDENCE FOR A REGULATORY FUNCTION OF NERVE GROWTH-FACTOR INVIVO [J].
DONNERER, J ;
SCHULIGOI, R ;
STEIN, C .
NEUROSCIENCE, 1992, 49 (03) :693-698
[10]   THE DEATH PROGRAM IN CULTURED SYMPATHETIC NEURONS CAN BE SUPPRESSED AT THE POSTTRANSLATIONAL LEVEL BY NERVE GROWTH-FACTOR, CYCLIC-AMP, AND DEPOLARIZATION [J].
EDWARDS, SN ;
BUCKMASTER, AE ;
TOLKOVSKY, AM .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (06) :2140-2143